[1]刘丽丽.右美托咪定联合舒芬太尼对体外循环心脏瓣膜置换术患者围术期器官保护及术后认知功能的影响[J].医学信息,2022,35(17):95-98.[doi:10.3969/j.issn.1006-1959.2022.17.025]
　LIU Li-li.Effects of Dexmedetomidine Combined with Sufentanil on Perioperative Organ Protection and Postoperative Cognitive Function in Patients Undergoing Cardiopulmonary Bypass Cardiac Valve Replacement[J].Journal of Medical Information,2022,35(17):95-98.[doi:10.3969/j.issn.1006-1959.2022.17.025]
点击复制

右美托咪定联合舒芬太尼对体外循环心脏瓣膜置换术患者围术期器官保护及术后认知功能的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年17期
页码:
95-98
栏目:
论著
出版日期:
2022-09-01

文章信息/Info

Title:
Effects of Dexmedetomidine Combined with Sufentanil on Perioperative Organ Protection and Postoperative Cognitive Function in Patients Undergoing Cardiopulmonary Bypass Cardiac Valve Replacement
文章编号:
1006-1959（2022）17-0095-04
作者:
刘丽丽
（佳木斯市中心医院麻醉科，黑龙江 佳木斯 154002）
Author(s):
LIU Li-li
(Department of Anesthesiology,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China)
关键词:
心脏瓣膜置换术; 体外循环; 右美托咪定; 舒芬太尼; 器官保护; 认知功能
Keywords:
Cardiac valve replacement; Cardiopulmonary bypass; Dexmedetomidine; Sufentanil; Organ protection; Cognitive function
分类号:
R614
DOI:
10.3969/j.issn.1006-1959.2022.17.025
文献标志码:
A
摘要:
目的 研究右美托咪定联合舒芬太尼对体外循环（CPB）心脏瓣膜置换术患者围术期器官保护及术后认知功能的影响。方法 选取2019年5月-2021年5月于我院行CPB下心脏瓣膜置换术治疗的80例患者为研究对象，随机分为对照组与观察组，各40例。对照组全程采用舒芬太尼镇痛，观察组则采用右美托咪定联合舒芬太尼镇痛，比较两组术后VAS疼痛评分、围术期麻醉药物使用量、围术期器官保护作用及术后认知功能。结果 观察组术后1、3 d VAS评分低于对照组，差异有统计学意义（P＜0.05）；观察组围术期麻醉药物使用量小于对照组，差异有统计学意义（P＜0.05）；术后1 d，两组肝脏、肾脏、心脏损伤指标均有升高，但观察组低于对照组，差异有统计学意义（P＜0.05）；观察组术后MMSE、MoCA评分高于对照组，差异有统计学意义（P＜0.05）。结论 右美托咪定联合舒芬太尼可提升CPB心脏瓣膜置换术患者的术后镇痛效果，减少麻醉药物用量，对患者心、肝、肾器官具有较好保护作用，有利于减轻术后认知功能损害。
Abstract:
Objective To study the effects of dexmedetomidine combined with sufentanil on perioperative organ protection and postoperative cognitive function in patients undergoing cardiopulmonary bypass (CPB) cardiac valve replacement.Methods A total of 80 patients who underwent CPBcardiac valve replacement in our hospital from May 2019 to May 2021 were randomly divided into control group and observation group, with 40 cases in each group. The control group was treated with sufentanil for analgesia, while the observation group was treated with dexmedetomidine combined with sufentanil for analgesia. The postoperative VAS pain score, perioperative anesthetic dosage, perioperative organ protection and postoperative cognitive function were compared between the two groups.Results The VAS score of the observation group was lower than that of the control group at 1 and 3 days after operation, and the difference was statistically significant (P<0.05). The amount of anesthetics used in the observation group was less than that in the control group, and the difference was statistically significant (P<0.05). One day after operation, the indexes of liver, kidney and heart injury in the two groups increased, but those in the observation group were lower than the control group, and the differences were statistically significant (P<0.05). The MMSE and MoCA scores of the observation group were higher than those of the control group, and the difference was statistically significant (P<0.05).Conclusion Dexmedetomidine combined with sufentanil can improve the postoperative analgesic effect of patients undergoing CPBcardiac valve replacement, reduce the dosage of anesthetic drugs, and have a good protective effect on the heart, liver and kidney organs, which is conducive to reducing postoperative cognitive impairment.

参考文献/References:

[1]严晓晴,王翔,马明华.右美托咪定对心脏瓣膜置换术患者心肌氧供、体循环及肺循环的影响研究[J].中国处方药,2021,19(9):119-121.[2]吴鹏涛,魏来.右美托咪定联合舒芬太尼对心脏瓣膜置换术麻醉患者心肌的保护作用及血流动力学的影响[J].中国药业,2021,30(17):46-49.[3]李扬,王华,胡颖,等.右美托咪定联合舒芬太尼对心脏手术患者麻醉苏醒期心血管应激及躁动的影响[J].检验医学与临床,2018,15(13):1869-1871.[4]丁刘欣.右美托咪定对心脏瓣膜置换术患者围术期应激水平及镇静评分的影响[J].河南外科学杂志,2021,27(2):5-7.[5]廖益永,黄典,袁鸿乾.右美托咪定对体外循环下心脏瓣膜置换术患者多脏器损伤及细胞免疫功能的影响[J].山东医药,2021,61(5):69-72.[6]黄振强.探讨右美托咪定对心脏瓣膜置换术患者麻醉诱导期血流动力学的影响[J].中医临床研究,2021,13(2):39-42.[7]敖小华.超声评价舒芬太尼联合右美托咪定对心脏瓣膜置换术患者器官的保护作用[J].上海医药,2020,41(21):21-24.[8]刘旭芳.右美托咪定麻醉诱导对心脏瓣膜置换术患者心肌指标及脑代谢指标的影响[J].中国实用医刊,2020,47(17):69-72.[9]刘慧芳,都义日.右美托咪定复合舒芬太尼对瓣膜置换术病人术后镇痛及快速康复的观察[J].中国疼痛医学杂志,2020,26(8):635-638.[10]王丽,林涵淼,邢珍,等.右美托咪定超前镇痛对体外循环下行心脏瓣膜置换术患者肺炎性反应的影响[J].山东医药,2017,57(28):57-59.[11]刘超,刘锴,罗纲,等.右美托咪定对心脏瓣膜置换术者围术期的神经保护作用及认知水平的影响[J].中国临床研究,2020,33(7):913-916.[12]邓莎,庄海滨,刘金花.右美托咪定用于体外循环下心脏瓣膜置换术患者临床观察[J].临床军医杂志,2016,44(1):81-84.[13]方闻,陈敏,林伟巍.右美托咪定联合舒芬太尼在心脏瓣膜置换手术麻醉中对心肌保护作用研究[J].心血管病防治知识,2020,10(14):3-5.[14]张金辉,蔡淑女.右美托咪定全程泵注对体外循环下心脏瓣膜置换术患者的心肌保护作用[J].中华全科医学,2020,18(5):752-756.[15]杨征,靳彦涛,徐莉莉.右美托咪定对心脏瓣膜置换术后炎症指标、认知功能及诱导期血流动力学影响研究[J].临床军医杂志,2020,48(2):226-227,229.[16]Abd-Elshafy SK,Abdallal F,Sd E,et al.Paravertebral Dexmedetomidine in Video- Assisted Thoracic Surgeries for Acute and Chronic Pain Prevention[J].Pain physician,2019,22(3):271-280.[17]杨超.舒芬太尼镇痛复合右美托咪定浅镇静在心脏瓣膜置换术后入住ICU患者中的应用价值[J].现代诊断与治疗,2019,30(7):1047-1048.[18]许静红,肖亮灿,徐夏,等.右美托咪定对成人瓣膜置换术围术期心肺保护作用[J].齐鲁医学杂志,2016,31(4):414-416.[19]李青.右美托咪定复合舒芬太尼在体外循环下心脏瓣膜置换术后镇痛中的应用效果观察[J].中外医学研究,2019,17(3):24-26.[20]陈秋,董燕斐,陈权涛.右美托咪定对体外循环下心脏瓣膜置换术患者脑损伤的保护作用[J].右江医学,2018,46(3):334-337.[21]唐金清,潘佳美,韩明,等.右美托咪定对心脏瓣膜置换术患者麻醉诱导期血流动力学的影响[J].广东医学,2018,39(9):1297-1300.[22]隆雨秋,张莉,陈均,等.右美托咪定联合舒芬太尼对体外循环下心脏瓣膜置换术患者血流动力学的影响及心肺功能的保护作用研究[J].实用心脑肺血管病杂志,2021,29(7):80-85.[23]杨璐,孙振涛.右美托咪定对心脏瓣膜置换术患者脑代谢影响及脑保护价值探讨[J].河南医学研究,2017,26(24):4486-4487.[24]龚拯.舒芬太尼联合右美托咪定对体外循环心脏瓣膜置换术患者围术期器官保护和术后认知功能的影响[D].南宁:广西医科大学,2018.[25]Elgebaly AS,Fathy SM,Sallam AA,et al.Cardioprotective Effects of Propofol Dexmedetomidine in Open Heart Surgery:A Prospective Double Blind Study[J].Annals of Cardiac Anaesthesia,2020,23(2):134-141.[26]薛峰,张伟,张晓,等.右美托咪定对体外循环下瓣膜置换术后患者急性肾损伤的影响[J].中华麻醉学杂志,2016,36(10):1171-1174.

相似文献/References:

[1]黄 勃.心脏手术后并发急性肾功能损伤的研究进展[J].医学信息,2018,31(03):52.[doi:10.3969/j.issn.1006-1959.2018.03.017]
　HUANG Bo.Progress in the Study of Acute Renal Injury after Cardiac Surgery[J].Journal of Medical Information,2018,31(17):52.[doi:10.3969/j.issn.1006-1959.2018.03.017]
[2]张雅静,卢树军,齐庆玲.右美托咪定预充对体外循环下心脏手术患者肾功能的影响[J].医学信息,2018,31(20):131.[doi:10.3969/j.issn.1006-1959.2018.20.039]
　ZHANG Ya-jing,LU Shu-jun,QI Qing-ling.Effect of Dexmedetomidine Prefilled on Renal Function in Patients undergoing Cardiac Surgery under Cardiopulmonary Bypass[J].Journal of Medical Information,2018,31(17):131.[doi:10.3969/j.issn.1006-1959.2018.20.039]
[3]朱金伟,刘 聪,刘忠民,等.右美托咪定对体外循环术后患者的心脏保护作用的研究[J].医学信息,2019,32(08):4.[doi:10.3969/j.issn.1006-1959.2019.08.002]
　ZHU Jin-wei,LIU Cong,LIU Zhong-min,et al.Cardiac Protective Effect of Dexmedetomidine on Patients after Cardiopulmonary Bypass[J].Journal of Medical Information,2019,32(17):4.[doi:10.3969/j.issn.1006-1959.2019.08.002]
[4]黄子钊,蒋迎九.心外膜临时起搏在心内直视手术后的应用[J].医学信息,2019,32(10):57.[doi:10.3969/j.issn.1006-1959.2019.10.020]
　HUANG Zi-zhao,Jiang Ying-jiu.Application of Epicardial Temporary Pacing after Open Heart Surgery[J].Journal of Medical Information,2019,32(17):57.[doi:10.3969/j.issn.1006-1959.2019.10.020]
[5]季景媛,张 静.早期综合康复护理干预对换瓣术后患者康复的影响[J].医学信息,2020,33(07):178.[doi:10.3969/j.issn.1006-1959.2020.07.060]
　JI Jing-yuan,ZHANG Jing.Effect of Early Comprehensive Rehabilitation Nursing Intervention on Rehabilitation of Patients After Valve Replacement[J].Journal of Medical Information,2020,33(17):178.[doi:10.3969/j.issn.1006-1959.2020.07.060]
[6]冯文娜,吴 雷.连续性肾脏替代治疗中体外循环凝血的原因分析及预防对策[J].医学信息,2020,33(08):183.[doi:10.3969/j.issn.1006-1959.2020.08.063]
　FENG Wen-na,WU Lei.Causes and Preventive Measures of Extracorporeal Circulation Coagulation in Continuous Renal Replacement Therapy[J].Journal of Medical Information,2020,33(17):183.[doi:10.3969/j.issn.1006-1959.2020.08.063]
[7]魏一鸣.乌司他丁对体外循环二尖瓣置换术患者肺功能损伤及炎性因子的影响[J].医学信息,2020,33(09):142.[doi:10.3969/j.issn.1006-1959.2020.09.046]
　WEI Yi-ming.Effect of Ulinastatin on Lung Function Injury and Inflammatory Factors in Patients Undergoing Mitral Valve Replacement with Cardiopulmonary Bypass[J].Journal of Medical Information,2020,33(17):142.[doi:10.3969/j.issn.1006-1959.2020.09.046]
[8]巫 菲,薛奋龙,陈洪磊,等.左西孟旦与米力农在心脏瓣膜置换术围术期的心肌保护作用[J].医学信息,2021,34(16):128.[doi:10.3969/j.issn.1006-1959.2021.16.035]
　WU Fei,XUE Fen-long,CHEN Hong-lei,et al.Myocardial Protection of Levosimendan and Milrinone During the Perioperative Period of Heart Valve Replacement[J].Journal of Medical Information,2021,34(17):128.[doi:10.3969/j.issn.1006-1959.2021.16.035]
[9]赵金香.早期康复护理对心脏瓣膜置换术后并发症与康复效果的影响[J].医学信息,2022,35(06):190.[doi:10.3969/j.issn.1006-1959.2022.06.051]
　ZHAO Jin-xiang.Effect of Early Rehabilitation Nursing on Complications and Rehabilitation After Cardiac Valve Replacement[J].Journal of Medical Information,2022,35(17):190.[doi:10.3969/j.issn.1006-1959.2022.06.051]
[10]程国佳.基于思维导图的延续性护理干预对提高心脏瓣膜置换术后患者抗凝效果的影响[J].医学信息,2023,36(10):186.[doi:10.3969/j.issn.1006-1959.2023.10.043]
　CHENG Guo-jia.The Effect of Continuous Nursing Intervention Based on Mind Mapping on Improving the Effect of Anticoagulant Effect in Patients After Heart Valve Replacement[J].Journal of Medical Information,2023,36(17):186.[doi:10.3969/j.issn.1006-1959.2023.10.043]

更新日期/Last Update: 1900-01-01